Rapt Therapeutics to Showcase FLX475 Phase 1/2 Results at ESMO Immuno-Oncology Annual Congress

RAPT Therapeutics to Present FLX475 Phase 1/2 Data at the European Society for Medical Oncology Immuno-Oncology Congress Exciting News from RAPT Therapeutics SOUTH SAN FRANCISCO, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT” or the “Company”), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule…

Read More

Unveiling Success: Edge Total Intelligence Inc. Releases Third Quarter 2022 Results and Exciting Operational Outlook

Edge Total Intelligence Inc. Reports Third Quarter 2022 Results and Provides Operational Overview ARLINGTON, Va., Nov. 30, 2022 (GLOBE NEWSWIRE) — Edge Total Intelligence Inc. Financial Highlights Edge Total Intelligence Inc. (TSXV: CTRL, OTC: UNFYF, FSE: Q5i) announced its operating and consolidated results for the third quarter of 2022. The financial information is expressed in…

Read More

UnitedHealthcare to Pay $10 Million for Underpaying Frontline Clinicians at TeamHealth – A Shocking Revelation!

UnitedHealthcare Owes $10 Million for Underpaying Frontline Clinicians – TeamHealth Wins Legal Battle The Backstory UnitedHealthcare (United) has once again found themselves in hot water for putting profits over the well-being of patients and healthcare providers. In a recent legal battle, United was found guilty of intentionally and systematically underpaying TeamHealth clinicians. This unethical practice…

Read More